Evidence map›Paper›PMID 37970122›Full record

ArticleReumatologia2023

Depression, anxiety, and quality of life in patients with systemic lupus erythematosus.

Ali Dehghan, Hamidreza Soltani, Seyedeh Tahereh Faezi, Azarakhsh Baghdadi, Hossein Soleymani Salehabadi, Hamidreza Bashiri, Roya Hemayati, Mehrdad Mansouri, Mohammad Motaghi, Mohammad Nejadhosseinian

Open access · diamondAbstract read
In one paragraph

Article in Reumatologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ali DehghanRheumatology Research Center, Tehran University of Medical Sciences, Iran.ORCID https://orcid.org/0000-0001-9291-6419
Hamidreza SoltaniDepartment of Internal Medicine, Rheumatology, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Seyedeh Tahereh FaeziRheumatology Research Center, Tehran University of Medical Sciences, Iran.ORCID https://orcid.org/0000-0002-5828-7556
Azarakhsh BaghdadiRheumatology Research Center, Tehran University of Medical Sciences, Iran.ORCID https://orcid.org/0000-0003-0783-9207
Hossein Soleymani SalehabadiDepartment of Internal Medicine, Rheumatology, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.ORCID https://orcid.org/0000-0002-3558-9818
Hamidreza BashiriDepartment of Internal Medicine, Rheumatology, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Roya HemayatiDepartment of Internal Medicine, Nephrology, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.ORCID https://orcid.org/0000-0001-6575-8937
Mehrdad MansouriHealth System Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Mohammad MotaghiRheumatology Research Center, Tehran University of Medical Sciences, Iran.
Mohammad NejadhosseinianDepartment of Orthopedic Surgery, Tehran University of Medical Sciences, Iran.ORCID https://orcid.org/0000-0002-7977-5129
Shahid Sadoughi University of Medical Sciences and Health Services · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Systemic lupus erythematosus (SLE) is a multisystem disorder that can affect multiple organs; psychiatric manifestations including depression and anxiety are commonly seen in SLE. The aim of this study is to explore the prevalence of depression, anxiety, and stress, and assess the quality of life (QOL) in patients with SLE and also evaluate associated risk factors. Material and methods: In this cross-sectional study, adult patients with SLE were identified through our institution's SLE data registry. Participants were evaluated with three questionnaires: Depression, Anxiety, and Stress Scale (DASS-42), General Health Ouestionnaire-28 (GHQ-28), and World Health Organization quality of life instrument short form (WHO-QOL BREF). Results: A total of 222 patients were included in the study, 203 (91%) of whom were female and 19 were male (9%). Participants had a mean age of 35.6 ±9.5 years. According to DASS-42 questionnaire, 22.1%, 28.7% and 20.3% of patients had varying degrees of depression, anxiety, and stress, respectively. Based on GHQ-28 questionnaire, 137 (62%) of patients reported some degree of distress. Quality of life score was 12.8, 13, 14.3, and 13.9 in physical health, psychological health, social relationships, and environmental health, respectively. Conclusions: We found that depression, anxiety, and stress are common in patients with SLE, and quality of life is significantly affected. A high percentage of patients with SLE deal with some degree of distress. Routine evaluation of the quality of life and psychological disturbances is recommended in patients with SLE. Non-pharmacological interventions as well as specialist referral should be considered in patients with anxiety, depression, or stress.

Indexed as

anxietydepressionquality of lifestresssystemic lupus erythematosus

Identifiers

PMID37970122
PMCPMC10634407
OpenAlexW4387105967

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.